SCHEMBL16627067

SCHEMBL16627067

CC1/C(=N/N)Sc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17991574 0.82 HTR5A (0.33)
SCHEMBL17991572 0.78 CYP2D6 (0.30)
SCHEMBL904813 0.77 MAOA (0.41)
SCHEMBL21311912 0.65 TYMS (0.46)
SCHEMBL11588872 0.64 ALDH1A1 (0.41)
SCHEMBL12401961 0.63 ALOX5 (0.42)
SCHEMBL88255 0.63 HTR2A (0.46)
SCHEMBL5133396 0.63 MAOA (0.41)
SCHEMBL21312280 0.62 LMNA (0.33)
SCHEMBL12152287 0.61 NOX1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222432-A1 TEST STRIP USING FORMALDEHYDE OR PEROXIDE, FROM AMONG SARCOSINE METABOLITES, FOR DIAGNOSING PROSTATE CANCER, AND METHOD FOR DIAGNOSING PROSTATE CANCER USING SAME CSQUARE CO., LTD (KR) 2016-08-04 US disclosed
US-20160222432-A1 TEST STRIP USING FORMALDEHYDE OR PEROXIDE, FROM AMONG SARCOSINE METABOLITES, FOR DIAGNOSING PROSTATE CANCER, AND METHOD FOR DIAGNOSING PROSTATE CANCER USING SAME CSQUARE CO., LTD (KR) 2016-08-04 US disclosed
WO-2015050366-A1 TEST STRIP USING FORMALDEHYDE OR PEROXIDE, FROM AMONG SARCOSINE METABOLITES, FOR DIAGNOSING PROSTATE CANCER, AND METHOD FOR DIAGNOSING PROSTATE CANCER USING SAME 주식회사 씨스퀘어 2015-04-09 WO disclosed